Flagship Pioneering Launches Serif Biomedicines with $50M for DNA Medicines on April 21, 2026 Get link Facebook X Pinterest Email Other Apps Flagship Pioneering has launched Serif Biomedicines with $50 million in initial funding.1 Serif aims to develop a new class of genetic medicines focused on DNA.1 Sources: 1. https://trial.medpath.com/news